Remove blog what-does-covid-19-mean-for-patients-in-clinical-trials
article thumbnail

Decentralized Clinical Trials in a Post-Pandemic Era

ACRP blog

Overview Decentralized clinical trials (DCTs) represent the shift towards implementing virtual research studies using digital health tools to gather data and monitor patient activity. During the COVID-19 pandemic, the clinical industry experienced significant disruption to traditional practices.

article thumbnail

Beginner’s Guide to Single IRB Mandates

Advarra

As the research community continues to seek clinical trial efficiencies designed to bring therapies to patients faster, more governing bodies are pushing for single institutional review board (single IRB) review as one way to streamline efforts. This blog provides a beginner’s overview of single IRB review in the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The FDA PDUFA VII Goals Letter (FY 2023-2027): A Review of Our Top 10 Commitments

FDA Law Blog

From new initiatives to facilitate faster reviews for new indications under the Split Real Time Application Review (STAR) pilot program, to bringing new meetings under PDUFA goals, to continued support for rare diseases and incorporation of the patient voice, the goals letter revealed a good number of welcome announcements.

article thumbnail

Serial Screening – FDA’s Kobayashi Maru

FDA Law Blog

Shapiro — We return to the subject of FDA’s role in effectively blocking most rapid antigen COVID tests from the U.S. NIH has been in communication with FDA to finalize a standardized clinical protocol for this purpose. To explain: Nearly all COVID-19 in-vitro diagnostic trials are single point analyses.